Gavin C K W Koh Selected Research

tixagevimab

10/2022	Efficacy and safety of intramuscular administration of tixagevimab-cilgavimab for early outpatient treatment of COVID-19 (TACKLE): a phase 3, randomised, double-blind, placebo-controlled trial.
1/2022	Intramuscular AZD7442 (Tixagevimab-Cilgavimab) for Prevention of Covid-19.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gavin C K W Koh Research Topics

Disease

10	Melioidosis 09/2020 - 10/2010
8	Vivax Malaria 01/2020 - 02/2016
5	Infections 01/2019 - 03/2011
3	Sepsis (Septicemia) 01/2013 - 12/2011
2	COVID-19 10/2022 - 01/2022
2	Thrombocytopenia (Thrombopenia) 09/2020 - 01/2017
2	Typhoid Fever (Typhoid) 04/2015 - 08/2014
2	Tuberculosis (Tuberculoses) 01/2013 - 01/2013
2	Diabetes Mellitus 06/2012 - 03/2011
1	Fever (Fevers) 10/2022
1	Disease Progression 10/2022
1	Parasitemia 01/2019
1	Pulmonary Tuberculosis 01/2017
1	Body Weight (Weight, Body) 12/2016
1	Glucosephosphate Dehydrogenase Deficiency 12/2016
1	Shock 04/2015
1	Inflammation (Inflammations) 08/2014
1	Colitis 08/2014
1	Chronic Disease (Chronic Diseases) 01/2013
1	Vitamin D Deficiency 01/2013
1	Critical Illness (Critically Ill) 06/2012
1	Acute Lung Injury 06/2012
1	Latent Infection 01/2012
1	Candidemia 12/2010

Drug/Important Bio-Agent (IBA)

8	tafenoquineIBA 01/2020 - 02/2016
3	Pharmaceutical PreparationsIBA 10/2022 - 12/2016
3	Primaquine FDA Link 01/2019 - 02/2016
2	AntigensIBA 10/2022 - 01/2017
2	tixagevimabIBA 10/2022 - 01/2022
2	cilgavimabIBA 10/2022 - 01/2022
2	von Willebrand FactorIBA 09/2020 - 01/2017
2	CytokinesIBA 01/2017 - 08/2014
2	EndotoxinsIBA 01/2017 - 04/2015
2	Thrombin FDA Link 01/2017 - 12/2011
2	Glyburide (Glibenclamide)FDA LinkGeneric 01/2013 - 03/2011
1	Monoclonal AntibodiesIBA 10/2022
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2022
1	cilgavimab and tixagevimab drug combinationIBA 01/2022
1	LigandsIBA 01/2019
1	FlagellinIBA 01/2019
1	Glucosephosphate Dehydrogenase (Glucose 6 Phosphate Dehydrogenase)IBA 01/2019
1	Toll-Like Receptor 5IBA 01/2019
1	8-aminoquinolineIBA 01/2018
1	piperaquineIBA 12/2016
1	artenimol (dihydroartemisinin)IBA 12/2016
1	Lumefantrine Drug Combination Artemether (Coartem)FDA Link 12/2016
1	Cytochrome P-450 CYP2D6 (CYP2D6)IBA 02/2016
1	Toll-Like Receptor 4IBA 04/2015
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 04/2015
1	Proteins (Proteins, Gene)FDA Link 04/2015
1	Interleukin-18 (Interleukin 18)IBA 08/2014
1	InterferonsIBA 01/2013
1	3,5-diisopropylsalicylic acid (DIPS)IBA 01/2013
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 01/2013
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2013
1	Vitamin D FDA LinkGeneric 01/2013
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 06/2012
1	VaccinesIBA 01/2012
1	Attenuated VaccinesIBA 01/2012
1	Protein CIBA 12/2011
1	Protein SIBA 12/2011
1	Fibrinolysin FDA Link 12/2011
1	Fibrinogen (Factor I)FDA Link 12/2011
1	AntithrombinsIBA 12/2011
1	Antifibrinolytic Agents (Antifibrinolytics)IBA 12/2011
1	AnticoagulantsIBA 12/2011
1	Prothrombin (Factor II)IBA 12/2011
1	fibrin fragment D (D-dimer)IBA 12/2011
1	Ceftazidime (Fortum)FDA LinkGeneric 11/2011
1	Amoxicillin-Potassium Clavulanate Combination (Co-amoxiclav)FDA Link 11/2011
1	Hypoglycemic Agents (Hypoglycemics)IBA 03/2011
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 03/2011
1	Adenosine Triphosphate (ATP)IBA 03/2011
1	InflammasomesIBA 03/2011
1	Interferon-gamma (Interferon, gamma)IBA 10/2010

Therapy/Procedure

3	Therapeutics 01/2019 - 06/2012
2	Secondary Prevention 01/2019 - 12/2016
2	Drug Therapy (Chemotherapy) 01/2013 - 01/2013
1	Central Venous Catheters 12/2010